Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

October 26, 2018

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2024

Conditions
DNA DamageGastric Cancer
Interventions
DIAGNOSTIC_TEST

investigated biomarkers regarding the efficacy of first-line chemotherapy

The present study was designed to generate solid evidence on the predictivity of the investigated biomarkers regarding the efficacy of first-line chemotherapy in patients with GC

Trial Locations (1)

00144

"Regina Elena National Cancer Institute", Rome

All Listed Sponsors
collaborator

Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti

OTHER

collaborator

Campus Bio-Medico University

OTHER

collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

collaborator

"Azienda Ospedaliera Sant'Andrea"

OTHER

collaborator

University of Roma La Sapienza

OTHER

collaborator

Azienda Ospedaliero Universitaria Policlinico Modena

OTHER

lead

Regina Elena Cancer Institute

OTHER

NCT06204523 - Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter